TGFB1 and colorectal carcinoma: Taken together, we propose that the CRC risk at chromosome 18q21.1 is due to the contributions of 4 functional variants in an enhancer affecting the expression of SMAD7, potentially leading to perturbed regulation of the BMP negative feedback loop in BMP/TGFβ signaling pathways.